Envoy Medical CFO David R. Wells departs; CEO Lucas becomes interim CFO

Envoy Medical, Inc.

David R. Wells ceased as CFO effective May 16, 2025, without cause.
Wells entitled to separation benefits per his August 2023 employment agreement.
CEO Brent T. Lucas will serve as interim principal financial officer.
Search for a permanent successor CFO has been initiated.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David R. Wells

Chief Financial Officer

COCH · Envoy Medical, Inc.

Effective: 2025-05-16
Filed: May 19, 2025, 7:59 PM ET

Effective May 16, 2025, David R. Wells ceased serving as Chief Financial Officer of Envoy Medical, Inc.

Appointed (interim)

Brent T. Lucas

principal financial officer

COCH · Envoy Medical, Inc.

Filed: May 19, 2025, 7:59 PM ET

The Company’s Chief Executive Officer, Brent T. Lucas, will serve as principal financial officer on an interim basis until a successor Chief Financial Officer is appointed.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

David R. Wells departed as Chief Financial Officer at Envoy Medical, Inc..

Action: ceased
Role: Chief Financial Officer

Exact text from the filing

Effective May 16, 2025, David R. Wells ceased serving as Chief Financial Officer of Envoy Medical, Inc.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Brent T. Lucas was appointed as principal financial officer at Envoy Medical, Inc..

Action: appointed
Role: principal financial officer

Exact text from the filing

The Company’s Chief Executive Officer, Brent T. Lucas, will serve as principal financial officer on an interim basis until a successor Chief Financial Officer is appointed.

View on SEC.gov

Envoy Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-045109

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.